<DOC>
	<DOCNO>NCT00600821</DOCNO>
	<brief_summary>To determine addition AG-013736 chemotherapy beneficial patient advanced lung cancer previously treat .</brief_summary>
	<brief_title>A Study Of AG-013736 ( Axitinib ) Or Bevacizumab ( Avastin ) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer .</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Axitinib</mesh_term>
	<criteria>Advanced non squamous cell , lung cancer No prior treatment lung cancer except prior adjuvant therapy last dose &gt; 12 month prior enrollment Prior therapy advance lung cancer The need bloodthinners Coughing blood</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>